FDA to launch drug marketing review

08/2/2005 | Wall Street Journal, The

The FDA is responding to criticism of drug manufacturers' direct-to-consumer advertising, a $4.1 billion industry in 2004, by launching a review of drug marketing. The review, which will examine issues such as the balance of drugs' risks and benefits in ads, the development and enforcement of guidelines, and the use of digital media, will begin with a public meeting to gather information and opinions.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Media

Job Title Company Location
Director, Industry Initiatives (Digital Video and AdvancedTV)
Interactive Advertising Bureau
New York, NY
Digital Ad Operations Specialist
Crain Communications
Nationwide, SL_Nationwide
Account Executive, West Coast
Los Angeles, CA
Web Developer
Crain's New York Business
New York, NY